Correction to: Molecular cross‑talk between long COVID‑19 and Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction to: Molecular cross‑talk between long COVID‑19 and Alzheimer’s disease ; volume:46 ; number:5 ; day:9 ; month:7 ; year:2024 ; pages:5393 ; date:10.2024
GeroScience ; 46, Heft 5 (9.7.2024), 5393, 10.2024
- Urheber
-
Pszczołowska, Magdalena
Walczak, Kamil
Miśków, Weronika
Antosz, Katarzyna
Batko, Joanna
Karska, Julia
Leszek, Jerzy
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11357-024-01271-4
- URN
-
urn:nbn:de:101:1-2411110958474.462352503111
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pszczołowska, Magdalena
- Walczak, Kamil
- Miśków, Weronika
- Antosz, Katarzyna
- Batko, Joanna
- Karska, Julia
- Leszek, Jerzy
- SpringerLink (Online service)
Ähnliche Objekte (12)
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease
Molecular analysis of Small Vessel Disease in Familial Alzheimer’s Disease
Molecular subtypes of Alzheimer’s disease
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Signaling pathway cross talk in Alzheimer’s disease
Small intestinal bacterial overgrowth in Alzheimer’s disease
Molecular mechanisms and genetics of Alzheimer’s disease
Blood-based molecular biomarkers for Alzheimer’s disease
Identification of repurposed drugs targeting significant long non-coding RNAs in the cross-talk between diabetes mellitus and Alzheimer’s disease
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Impact of IL-21-associated peripheral and brain crosstalk on the Alzheimer’s disease neuropathology
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease
Molecular analysis of Small Vessel Disease in Familial Alzheimer’s Disease
Molecular subtypes of Alzheimer’s disease
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Signaling pathway cross talk in Alzheimer’s disease
Small intestinal bacterial overgrowth in Alzheimer’s disease
Molecular mechanisms and genetics of Alzheimer’s disease
Blood-based molecular biomarkers for Alzheimer’s disease
Identification of repurposed drugs targeting significant long non-coding RNAs in the cross-talk between diabetes mellitus and Alzheimer’s disease
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Impact of IL-21-associated peripheral and brain crosstalk on the Alzheimer’s disease neuropathology
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease
Molecular analysis of Small Vessel Disease in Familial Alzheimer’s Disease
Molecular subtypes of Alzheimer’s disease
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Signaling pathway cross talk in Alzheimer’s disease
Small intestinal bacterial overgrowth in Alzheimer’s disease
Molecular mechanisms and genetics of Alzheimer’s disease
Blood-based molecular biomarkers for Alzheimer’s disease
Identification of repurposed drugs targeting significant long non-coding RNAs in the cross-talk between diabetes mellitus and Alzheimer’s disease
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics